Discovery Labs Reports Encouraging Results for AEROSURF Phase 2a Clinical Program in Premature Infants 29-34 Weeks
November 12, 2015 at 07:07 AM EST
Discovery Laboratories, Inc. (NASDAQ: DSCO) today reported top line data from its recently completed AEROSURF® phase 2a clinical program ...